Canary Wharf Group v The European Medicines Agency (EMA) has been the most eagerly anticipated case of the year so far with commentators predicting serious ramifications for the property industry if the EMA succeeded. The industry will however now be breathing a huge sigh of relief as the High Court gave short shrift to the EMA’s request that the court effectively tear up its lease in light of Brexit.
Read moreWelcome to the monthly update from the Life Sciences team at S&B containing news about recent and topical developments.
A link to the web version of this email update is available here. If you would like to receive these updates via email, please subscribe.